Rare diseases
Investigational molecules
Locations
346 conditions with trials, the busiest first
960 trials across Europe, recruiting first
Study on the Safety and Feasibility of PSMA-T4 for Prostate Cancer Patients
PolandStudy of Nivolumab After Initial Treatment in Patients with Metastatic Triple-Negative Breast Cancer
The NetherlandsStudy on Nivolumab and Cisplatin for Patients with Metastatic Triple Negative Breast Cancer
The NetherlandsStudy on the Use of PET Scans with Fludeoxyglucose (18F) for Diagnosing Endometriosis in Patients with Symptoms
FranceStudy of Ipilimumab and Nivolumab for Patients with Metastatic Castration-Resistant Prostate Cancer
The NetherlandsStudy on the Effectiveness and Safety of Datopotamab Deruxtecan Compared to Chemotherapy in Adults with Advanced Triple-negative Breast Cancer
BelgiumStudy on Chemotherapy and Aromatase Inhibitors (Exemestane, Letrozole, Anastrozole) for Post-Menopausal Patients with Early Breast Cancer
ItalyStudy Comparing Elacestrant and Standard Endocrine Therapy for Patients with Early Breast Cancer at High Risk of Recurrence
AustriaStudy on the Use of Indocyanine Green and Technetium (99mTc) Nanocolloid for Sentinel Node Biopsy in Patients with Melanoma, Oral Cancer, or Penile Cancer
The NetherlandsStudy on Radiometabolic Therapy with 177Lu-PSMA for Patients with Advanced or Metastatic Tumors
ItalyStudy on Talazoparib for Advanced Breast Cancer Patients Using the RECAP Test
The NetherlandsStudy on the Use of 18F-PSMA-1007, Piflufolastat (18F), and Gozetotide for Detecting Pelvic Lymph Node Invasion in Newly Diagnosed Prostate Cancer Patients
The NetherlandsThe therapies tested most often in Reproductive system and breast disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
